CURCUMIN, A NATURAL GOLDEN DRUG AND ITS ANTICANCER ASPECTS FROM SYNTHESIS TO DELIVERY: A REVIEW

  • GEETA KRISHNAMURTHY Department of Chemistry, MS Ramaiah University of Applied Sciences, Bangalore, India
  • DEEPTI ROY Department of Chemistry, MS Ramaiah University of Applied Sciences, Bangalore, India
  • JYOTSNA KUMAR Department of Chemistry, MS Ramaiah University of Applied Sciences, Bangalore, India

Abstract

Cancer is a dreadful disease and, in most cases, leads to death even when it is being treated. Even though synthetic drugs are still in use for the treatment of cancer, the seriousness of the side effects of these drugs has boggled researcher’s mind to find more effective drugs which will help to overcome the side effects and have greater potency in trying to make the patient completely free of the disease. Recently, researchers turned their attention towards bio-components present in natural products. Curcumin, a polyphenol and the main constituent of a rhizome Curcuma longa, has geared significant interest due to its wide spectrum of therapeutics values, especially anticancer activity. Paper summarizes the chemistry and bio-metabolism of curcumin in the human body. Aim of this review article is to gather the dispersed efforts of researchers predominantly in improving the bioavailability of curcumin. In the present review, comprehensive literature on anticancer activity of Curcumin via combination therapy, structure modification, synthesis of analogues, novel delivery systems have been highlighted. Besides, the review paper explicated several challenges associated with Curcumin as an adjuvant chemotherapeutic agent and emphasizes more on clinical studies.

Keywords: Curcumin, Curcuma longa, Drug delivery, Curcuminoids

References

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. Ca-Cancer J Clin 2018;68:7–30.
2. Gupta AP, Pandotra P, Sharma R, Kushwaha M, Gupta S. Marine resource: a promising future for anticancer drugs. Stud Nat Prod Chem 2013;40:229-325.
3. Momna H. Introduction to cancer biology. 2nd ed. Momna Hejmadi and bookboon.com; 2010.
4. Franks LM, Teich NM. Introduction to the cellular and molecular biology of cancer. New York: Oxford University Press; 1997.
5. Raymond WR. Cancer biology. 4th ed. New York: Oxford University Press; 2007.
6. O'Connor CM, Adams JU. Essentials of cell biology. Cambridge (MA): NPG Education; 2010.
7. Evelyn MS. Cancer characteristics and selection of cases. 3rd ed. United States: SEER Publications; 1992.
8. P Carmeliet, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249–57.
9. Tatiana CL, Luiza CS, Leila SM, Laura BC, Felipe SR, Edmilson OS, et al. IKK? targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: a potential anti-angiogenic therapeutic target. Lung Cancer 2019;130:169–78.
10. Hanahan D, Weinberg R. Unique characteristics of cancer cells # 1–cancer cells remain undifferentiated # 2–cancer cells lack normal cell signaling responses loss of contact inhibition: evade apoptosis. Cell 2011;144:646-74.
11. Pizzo P, Poplack D. Principles and practice of paediatric oncology. 7th ed. Philadelphia: Lippincott Williams and Wilkins; 2001.
12. Baskar R, Kuo AL, Richard YK. Cancer and radiation therapy: current advances and future directions. Int J Med Sci 2012;9:193-9.
13. Michael CP, Donald CD, Carl EF. Perry’s chemotherapy sourcebook. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2012.
14. Sarkar FH, Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 2006;66:3347–51.
15. Oiseth SJ, Aziz MS. Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead. J Cancer Metastasis Treat 2017;3:250-61.
16. Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature 2011;480:480–9.
17. Habib FK, Robinson MR, Stitch SR. Effects of tamoxifen on the binding and metabolism of testosterone by human prostatic tissue and plasma in vitro. J Endocrinol 1979;83:369-79.
18. Misra R, Sanjukta A. Human gene therapy: a brief overview of the genetic revolution. J Assoc Physicians India 2013;61:127-33.
19. Altanerova U, Jakubechova J, Benejova K, Priscakova P, Pesta M, Pitule P, et al. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes. Int J Cancer 2019;144:897–908.
20. Künnapuu K, Veiman K, Porosk L, Rammul E, Kiisholts K, Lange U, et al. Tumour gene therapy by systemic delivery of plasmid DNA with cell-penetrating peptides. FASEB BioAdv 2019;1:105–14.
21. Doran SL, Sanja S, Adhikary S, Jared JG, Jia L, Li MK, et al. T-cell receptor gene therapy for human papillomavirus-associated epithelial cancers: a first-in-human, phase I/II study. J Clin Oncol 2018;37:2759–68.
22. Umar A, Dunn BK, Greenwald P. Future directions in cancer prevention. Nat Rev Cancer 2012;12:835–48.
23. Long GV, Stroyakovskiy D, Gogas H, Levchenko E, Braud FJ, Larkin J, et al. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med 2014;371:1877-88.
24. Liu M, Yang X, Liu J, Zhao B, Cai W, Li Y. Efficacy and safety of BRAF inhibition alone versus combined BRAF and MEK inhibition in melanoma: a meta-analysis of randomized controlled trials. Onco Targets Ther 2017;8:32258-69.
25. Gach K, Szymanski J, Pomorska D, D?ugosz A, Modranka J, Janecki TA. Combined effects of anticancer drugs and new synthetic ?-methylene-?-lactones on MCF-7 cells. Tumor Biol 2015;36:5971-7.
26. Robert N, Leyland JB, Asmar L, Belt R, Ilegbodu D, Loesch D, et al. Randomized phase III study of trastuzumab, paclitaxel and carboplatin compared with trastuzumab and paclitaxel in women with HER-2–overexpressing metastatic breast cancer. J Clin Oncol 2020;24:2786-92.
27. Poon C, He C, Liu D, Lu K, Lin W. Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer. J Controlled Release 2015;201:90–9.
28. Shi K, Xue B, Jia Y, Yuan L, Han R, Yang F, et al. Sustained co-delivery of gemcitabine and cis-platinum via biodegradable thermosensitive hydrogel for synergistic combination therapy of pancreatic cancer. Nano Res 2019;12:1389–99.
29. Huang W, Chen L, Kang L, Jin M, Sun P, Xin X, et al. Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs. Adv Drug Delivery Rev 2017;115:82–97.
30. Lei M, Shutao G, Michael LC, Qi L. Nanoformulations for combination or cascade anticancer therapy. Adv Drug Delivery Rev 2017;115:3–22.
31. Prakash O, Kumar A, Kumar P, Prakash A. Anticancer potential of plants and natural products: a review. Am J Pharmacol Sci 2013;1:104-15.
32. Patwardhan B, Ashok DB, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci 2004;86:789-99.
33. Jamal A, Siddiqui A, Tajuddin, Jafri MA. Review on gastric ulcer remedies used in Unani system of medicine. Indian J Nat Prod Resour 2006;5:153–9.
34. Krup V, Prakash LH, Harini A. Pharmacological activities of turmeric (Curcuma longa Linn): a review. J Homeopathy Ayurvedic Med 2013;2:133.
35. Greenwell M, Rahman PK. Medicinal plants: their use in anticancer treatment. Int J Pharma Sci Res 2015;6:4103–12.
36. Vaghela H, Shah R, Parmar K. Biogenic synthesis of silver nanoparticles using Bauhinia variegata bark extract and its antibacterial efficacy. Int J Green Nanotechnol 2017;3:45–9.
37. Amarvani P, Aruna L, Londonkar R. Characterization of phyto-nanoparticles from Ficus krishnae for their antibacterial and anticancer activities. Drug Dev Ind Pharm 2017;44:377-84.
38. Capolupo A, Esposito R, Zampella A, Festa C, Riccio R, Tosco A. Determination of gymnemic acid I as a protein biosynthesis inhibitor using chemical proteomics. J Nat Prod 2017;80:909?15.
39. Chandran S, Ponnusamy T, Bheeman D, Kumar RR, Bellan CS. Dextran sulfate stabilized silver nanoparticle: next-generation efficient therapy for cancer. Int J Appl Pharm 2020;12:59-63.
40. Kumar VS, Reddy RB, Subbaiah GP, Kumar SS, Gurava AV. Anti-cancer potential of a mix of natural extracts of turmeric, ginger and garlic: a cell-based study. Egyptian J Basic Appl Sci 2017;4:332-44.
41. Gupta AP, Khan S, Manzoor MM, Yadav AK, Gupta RA. Anticancer curcumin: natural analogues and structure-activity relationship. Stud Nat Prod Chem 2017;54:335–401.
42. Goel A, Kunnumakkara AB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 2008;75:787–809.
43. Alibeiki F, Jafari N, Karimi MP. Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells. Biosci Rep 2017;7:1–9.
44. Nagahama K, Utsumi T, Kumano T, Maekawa S, Oyama NK. Discovery of a new function of curcumin which enhances its anticancer therapeutic potency. Biosci Rep 2016;6:1–14.
45. Aggarwal BB, Deb LP. Curcumin differs from tetrahydroCurcumin for molecular targets, signaling pathways and cellular responses. Molecules 2014;20:85–205.
46. Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad SA. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol 2017;174:1325–48.
47. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett 2008;267:133–64.
48. Biji TK, Singh A, Hiroyuki M. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol 2007;5:567–76.
49. Anand P, Kunnumakkara AB, Robert AN, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharma 2007;4:807–18.
50. Wen S, Shen W, Zhao W, Chuanhong W, Shuhui G, Tao H, et al. Chemical constituents and biological research on plants in the genus curcuma. Crit Rev Food Sci Nutr 2016;57:1–392.
51. Wan-Ibrahim WI, Sidik K, Kuppusamy UR. A high antioxidant level in edible plants is associated with genotoxic properties. Food Chem 2010;122:1139–44.
52. Angel GR, Nirmala M, Vimala BN. Essential oil composition of eight starchy curcuma species. Phytopharmacology 2013;4:96–105.
53. Venugopalan P, Mohan S, Deepthi TV. Biochemical studies on Curcuma amada extracts. Arch Appl Sci Res 2014;6:229–34.
54. Lee YL, Weng CC, Mau JL. Antioxidant properties of ethanolic and hot water extracts from the rhizome of Curcuma aromatica. J Food Biochem 2007;31:757–71.
55. Dhal Y, Deo B, Sahu RK. Comparative antioxidant activity of non-enzymatic and enzymatic extracts of Curcuma caesia roxb, an important medicinal plant. J Biotechnol 2012;7:17–22.
56. Boonmee A, Srisomsap C, Karnchanatat A, Sangvanich P. Biologically active proteins from Curcuma comosa roxb. rhizomes. J Med Plants Res 2011;5:5208–15.
57. Saputri FC, Jantan I. Effects of selected medicinal plants on human low-density lipoprotein oxidation, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals and human platelet aggregation. J Med Plants Res 2011;5:6182–91.
58. Rajan I, Rabindran R, Jayasree PR, Kumar PR. Antioxidant potential and oxidative DNA damage preventive activity of unexplored endemic species of Curcuma. Indian J Exp Biol 2014;52:133–8.
59. Zhang DM, Li Q, Ma DW, Zhang DY, Li F. Study on antifungal activity of oil from curcuma kwangsiensis. Anhui Daxue Xuebao Ziran Kexueban 2008a;32:81–4.
60. Vankar PS. Effectiveness of antioxidant properties of fresh and dry rhizomes of Curcuma longa (long and short varieties) with dry turmeric spice. Int J Food Eng 2008;4:10.
61. Manda KR, Adams C, Ercal N. Biologically important thiols in aqueous extracts of spices and evaluation of their in vitro antioxidant properties. Food Chem 2009;118:589–93.
62. Dinesha R, Thammanna GS, Harsha R, Srinivas L. Antioxidant and antimicrobial activity of partially purified protein from hot water extract of turmeric (Curcuma longa L). Pharmacologyonline 2010;1:996–1004.
63. Ramadas D, Srinivas A. Antioxidant effects of 28 kDa antioxidant protein from turmeric (Curcuma longa L). Asian J Pharm Clin Res 2011;4 Suppl 1:75–9.
64. Chandrasekaran CV, Sundarajan K, Edwin JR, Gururaja GM, Mundkinajeddu D, Agarwal A. Immune-stimulatory and anti-inflammatory activities of Curcuma longa extract and its polysaccharide fraction. Pharmacogn Res 2013;5:71–9.
65. Madan B, Gade WN, Ghosh B. Curcuma longa activates NF-kappa B and promotes adhesion of neutrophils to human umbilical vein endothelial cells. J Ethnopharmacol 2001;75:25–32.
66. Mohankumar S, McFarlane JR. An aqueous extract of Curcuma longa (turmeric) rhizomes stimulates insulin release and mimics insulin action on tissues involved in glucose homeostasis in vitro. Phytother Res 2011;25:396–401.
67. Azuine MA, Kayal JJ, Bhide SV. Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo[?]pyrene-induced genotoxicity and carcinogenicity. J Cancer Res Clin Oncol 1992;118:447–52.
68. Jin SR, Hong JH, Jung SH, Cho KH. Turmeric and laurel aqueous extracts exhibit in vitro anti-atherosclerotic activity and in vivo hypolipidemic effects in a zebrafish model. J Med Food 2011;14:247–56.
69. Zhang W, Liu D, Wo X, Zhang Y, Jin M, Ding Z. Effects of Curcuma longa on proliferation of cultured bovine smooth muscle cells and on expression of low density lipoprotein receptor in cells. China Med J 1999;112:308–11.
70. Rafatullah S, Tariq M, Al-Yahya MA, Mossa JS, Ageel AM. Evaluation of turmeric (Curcuma longa) for gastric and duodenal antiulcer activity in rats. J Ethnopharmacol 1990;29:25–34.
71. Chander H, Kulkarni SG, Berry SK. Effectiveness of turmeric powder and mustard oil as protectants in stored milled rice against the rice weevil Sitophilus oryzae. Int Pest Control 1991;33:94–7.
72. Prakash D, Suri S, Upadhyay G, Singh BN. Total phenol, antioxidant and free radical scavenging activities of some medicinal plants. Int J Food Sci Nutr 2007;58:18–28.
73. Idris NA, Nor FM, Ismail R, Mohamed S, Hassan CZ. Antioxidative acivity of Malaysian herb extracts in refined, bleached and deodorized palm olein. J Oil Palm Res 2008;20:517–26.
74. Jacob JN, Toloue M. Biological studies of turmeric oil, part 1:selective in vitro anticancer activity of turmeric oil (TO) and TO-paclitaxel combination. Nat Prod Commun 2013;8:807–10.
75. Yan W, Bowen WD, Hopson R, Mathew AE, Jacob JN. Biological studies of turmeric oil, part 2: isolation and characterization of turmeric oil components; cytotoxic activity against pancreatic cancer cells. Nat Prod Commun 2013;8:811–4.
76. Chan EW, Lim YY, Wong LF, Lianto FS, Wong SK, Lim KK, et al. Antioxidant and tyrosinase inhibition properties of leaves and rhizomes of ginger species. Food Chem 2008;109:477–83.
77. Sukari MA, Wah TS, Saad SM, Rashid NY, Rahmani M, Lajis NH, et al. Bioactive sesquiterpenes from Curcuma ochrorhiza and Curcuma heyneana. Nat Prod Res 2010;24:838–45.
78. Li H, Wei Y, Long Z, Huang Y, Cui J. Activity and chemical component analysis of the hexane extract from Curcuma phaeocaulis against pathogenic fungi. Sichuan Daxue Xuebao Ziran Kexueban 2011;48:191–5.
79. Chen IN, Chang CC, Ng CC, Wang CY, Shyu YT, Chang TL. Antioxidant and antimicrobial activity of zingiberaceae plants in taiwan. Plant Foods Hum Nutr (NY, NY, US) 2008;63:15–20.
80. Lou Y, Xiang Z, Chen R, Li L, Gao H, Li X. Antioxidant activities in vitro of different solvent extracts from curcuma wenyujin root tubers. Shipin Kexue (Beijing, China) 2012;33:39–43.
81. Qader SW, Abdulla MA, Chua LS, Najim N, Zain MM, Hamdan S. Antioxidant, total phenolic content and cytotoxicity evaluation of selected Malaysian plants. Molecules 2011;16:3433–43.
82. Ullah HM, Zaman S, Juhara F, Akter L, Tareq SM, Masum EH, et al. Evaluation of antinociceptive, in vivo and in vitro anti-inflammatory activity of ethanolic extract of curcuma zedoaria rhizome. BMC Complementary Altern Med 2014;14:346.
83. Hong CH, Hur SK, Oh OJ, Kim SS, Nam KA, Lee SK. Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxi de synthase (iNOS) in cultured mouse macrophage cells. J Ethnopharmacol 2002;83:153–9.
84. Lu B, Yu L, Xu L, Chen H, Zhang L, Zeng Y. The effects of radix curcumae extract on expressions of VEGF, COX-2 and PCNA in gastric mucosa of rats fed with MNNG. Curr Pharm Biotechnol 2010;11:313–7.
85. Hadem KL, Sen A. Curcuma species: a source of anticancer drugs. J Tumor Med Prevention 2017;1:34-140.
86. Policegoudra RS, Chandrasekhar R, Aradhya SM, Singh L. Cytotoxicity, platelet aggregation inhibitory and antioxidant activity of Curcuma amada roxb. Extracts Food Technol Biotechnol 2011;49:162-8.
87. Gonzalzez MA, Mancebo AJ, Tangarife CV. Synthesis and biological evaluation of (þ)-labdadienedial, derivatives and precursors from (þ)-sclareolide. Eur J Med Chem 2010;45:4403-8.
88. Bing H, Shen K, An H, Wu Y, Du Q. Aqueous extract of Curcuma aromatica induces apoptosis and G2/M arrest in human colon carcinoma LS-174-T cells independent of p53. Cancer Biother Radiopharm 2011;26:97-104.
89. Li Y, Wo JM, Liu Q, Li XM. Chemoprotective effects of Curcuma aromatica on esophageal carcinogenesis. Ann Surg Oncol 2009;16:515-23.
90. Shaikh AM, Shrivastava B, Apte KG, Parab PB. In vitro screening of some medicinal plants on breast, ovary and colon cancer cell lines. Int J Pharma Bio Sci 2016;7:11-7.
91. Mohammad P, Nosratollah Z, Mohammad R, Abbas JR. The inhibitory effect of Curcuma longa extract on telomerase activity in A549 lung cancer cell line. Afr J Biotechnol 2010;9:912-91.
92. Karsono AH, Mayasari O, Tandrasasmita TR. Molecular effects of bioactive fraction of Curcuma mangga (DLBS4847) as a down regulator of 5?-reductase activity pathways in prostatic epithelial cells. Cancer Manage Res 2014;6:267-78.
93. Rouhollahi E, Moghadamtousi SZ, Al HN, Kunasegaran T, Hasanpourghadi M. The chemopreventive potential of Curcuma purpurascens rhizome in reducing azoxymethaneinduced aberrant crypt foci in rats. BMC Complementary Altern Med 2015;15:15.
94. Hong SL, Lee GS, Syed AR, Abdalla AH, Khalijah A, Nurfina AN, et al. Essential oil content of the rhizome of curcuma purpurascens Bl. (Temu Tis) and its anti-proliferative effect on selected human carcinoma cell lines. Sci World J 2014;7:1-7.
95. Oon FS, Nallappan M, Tee TT, Shohaimi S, Kassim NK, Mohd SF, et al. Xanthorrhizol: a review of its pharmacological activities and anticancer properties. Cancer Cell Int 2015;15:100.
96. Seo WG, Hwang JC, Kang SK, Jin UH, Suh SJ, Moon SK, et al. Suppressive effect of Zedoariae rhizoma on pulmonary metastasis of B16 melanoma cells. J Ethnopharmacol 2005;101:249-57.
97. Pal P, Prasad AK, Chakraborty M, Haldar S, Majumder P, Haldar PK. Evalaution of anticancer potential of methanol extract of Curcuma zedoaria. Asian J Pharm Clin Res 2015;7:309-13.
98. Tanzeela N, Muneeb I, Ahmad R, Madiha SF. Turmeric: a promising spice for phytochemical and antimicrobial activities. Am Eurasian J Agric Environ Sci 2015;15:1278–88.
99. Prasad S, Bharat BA. Turmeric, the golden spice: from traditional medicine to modern medicine. In: Benzie IF, Wachtel GS. editors. Herbal medicine: biomolecular and clinical aspects. 2nd ed. Boca Raton (FL): CRC Press/Taylor and Francis; 2011.
100. Grykiewicz G, Silfirski P. Curucmin and curcuminoids in quest for medicinal status. Acta Biochim Pol 2012;59:201–12.
101. Kocaadam B, ?anlier N. Curcumin, an active component of turmeric (Curcuma longa) and its effects on health. Crit Rev Food Sci Nutr 2015;57:2889–95.
102. Esatbeyoglu T, Huebbe P, Ernst I, Chin D, Wagner A, Rimbach G. Curcumin-from molecule to biological function. Angew Chem 2012;51:5308-32.
103. Gupta SC, Prasad S, Kim J, Patchva S, Webb L, Priyadarsini KI, et al. Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep 2011;28:1937–55.
104. Priyadarsini KI. Chemical and structural features influencing the biological activity of curcumin chemical and structural features influencing the biological activity of curcumin. Curr Pharm Des 2013;19:2093-100.
105. Priyadarsini KI. Photochemistry reviews photophysics, photochemistry and photobiology of curcumin: studies from organic solutions, bio-mimetics and living cells. J Photochem Photobiol 2009;10:81–95.
106. Kulkarni SJ, Maske KN, Budre MP, Mahajan RP. Extraction and purification of curcuminoids from turmeric (Curcuma longa L). Int J Pharmacol Pharm Technol 2012;1:81-4.
107. Pabon HJ. A synthesis of curcumin and related compounds. Recl Trav Chim Pays Bas 1964;83:379–86.
108. C Wehrli. World intellect. Prop Organ Int Bur WO 110168; 2007.
109. Joseph L, George M, Dheeraj MM. Synthesis and spectral characterization of curcumin and related curcuminoids. Pharm Chem J 2016;3:39–44.
110. Metzler M, Pfeiffer E, Schulz SI, Dempe JS. Review article: curcumin uptake and metabolism. Biofactors 2012;39:14-20.
111. Tsuda T. Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives. Food Funct 2018;9:705–14.
112. Shengfeng P, Li Z, Zou L, Liu WC, McClements DJ. Enhancement of curcumin bioavailability by encapsulation in sophorolipid-coated nanoparticles: an in vitro and in vivo study. J Agric Food Chem 2018;66:1488–97.
113. Suryani WA, Musnina OS, Ruslin, Nisa M, Aprianti R, Hasanah M, et al. Formulation and physical characterization of curcumin nanoparticle transdermal patch. Int J Appl Pharm 2019;11:217-21.
114. Kharat M, Du Z, Zhang G, Mcclements DJ. Physical and chemical stability of Curcumin in aqueous solutions and emulsions: impact of pH, temperature, and molecular environment. J Agric Food Chem 2017;65:1525?32.
115. Oskouie MN, Moghaddam BE, Alexandra NS, Zamani, Parvin AS. Therapeutic use of curcumin?encapsulated and curcumin-primed exosomes. J Cell Physiol 2018;234:1–10.
116. Sauraj S, Kumar U, Kumar V, Priyadarshi R, Gopinath P. pH responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy. Carbohydr Polym 2018;188:252–9.
117. Sreeraj G, Augustine A, Joby JN, Sabu TQ. Preparation, characterization and in vitro study of liposomal curcumin powder by cost effective nanofiber weaving technology. New J Chem 2018;7:1–37.
118. Nayek S, Venkatachalam A, Choudhury S. Recent nanocochleate drug delivery system for cancer treatment: a review. Int J Curr Pharm Res 2019;11:28-32.
119. Teymouri M, Barati N, Pirro M. Biological and pharmacological evaluation of dimethoxy curcumin: a metabolically stable curcumin analogue with a promising therapeutic potential. J Cell Physiol 2016;233:1–39.
120. Banuppriya G, Shakambari G, Sribalan R, Varalakshmi P, Padmini V. Evaluation of anticancer activity of water-soluble curcumin through the induction of apoptosis by p53 and p21 modulation. Chem Select 2018;3:2976–81.
121. Zhang Z, Luo D, Xie J, Lin G, Liu W, Li H, et al. Octahydro curcumin, a final hydrogenated metabolite of curcumin, possesses superior anti-tumor activity through induction of cellular apoptosis. Food Funct 2018;9:2005-14.
122. Jalde SS, Kumar A, Hoon J, Kumar P. Synthesis of novel chlorin e6-curcumin conjugates as photosensitizers for photodynamic therapy against pancreatic carcinoma. Eur J Med Chem 2018;147:66–76.
123. Ramezani M, Hatamipour M, Sahebkar A. Promising anti-tumor properties of bisdemethoxy curcumin: a naturally occurring curcumin analogue. J Cell Physiol 2018;233:880–7.
124. Cheng Y, Zhao P, Wu S, Yang T, Chen Y, Xiaojuan, et al. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. Int J Green Pharm 2018;545:261–73.
125. Chen S, Liang Q, Xie S, Liu E, Yu Z, Sun L, et al. Curcumin based combination therapy for anti-breast cancer: from in vitro drug screening to in vivo efficacy evaluation. Front Chem Sci Eng 2016;10:383–8.
126. Falah RR, Talib WH, Shbailat SJ. Combination of metformin and curcumin targets breast cancer in mice by angiogenesis inhibition, immune system modulation and induction of p53 independent apoptosis. Ther Adv Med Oncol 2017;9:235–52.
127. Banerjee S, Santosh KS, Indrajit C, James WL, Singh R. Combinatorial effect of Curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer. Front Biosci Elite Ed 2017;9:235–45.
128. Huarong H, Xuan C, Dongli L, Yan H, Yu L, Zhiyun D, et al. Combination of ?-tomatine and curcumin inhibits growth and induces apoptosis in human prostate cancer cells. PLoS One 2015;10:1-15.
129. Zhang J, Lin M, Zhou M, Yi T, Tang Y, Tang S, et al. Combinational treatment of curcumin and quercetin against gastric cancer MGC-803 cells in vitro. Molecules 2015;20:11524–34.
130. Ergul MA, Ay?e MY, Semra KT, Yalç?n S. Synergistic induction of apoptosis by quercetin and curcumin in chronic myeloid leukemia (K562) cells. Nutr Cancer 2018;70:1-12.
131. Regassa BL, Vaidya A. Curcumin and extracellular matrix proteins synergistically act to inhibit the proliferation of breast cancer cells. Breast Cancer Manage 2016;5:14.
132. Vemuri S, Banala R, Subbaiah G, Srivastava S, Reddy G, Malarvili T. Anti-cancer potential of a mix of natural extracts of turmeric, ginger and garlic: a cell-based study. Egyptian J Basic Appl Sci 2017;4:332-44.
133. Shindikar A, Singh A, Nobre M, Kirolikar S. Curcumin and resveratrol as promising natural remedies with nanomedicine approach for the effective treatment of triple negative breast cancer. J Oncol 2016;16:13.
134. Gandhi DM. Immuno-modulatory effect of turmeric (Curcuma longa) and aloe vera on cultured polymorphonuclear cells (PMN) and adherent mononuclear cells. Web Med Central Altern Med 2016;7:1–7.
135. Panda AK, Chakraborty D, Sarkar I, Khan T, Sa G. New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol 2017;9:31–45.
136. Chakravarti N, Myers JN. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int J Cancer 2006;19:1268–75.
137. LoTempio MM, Veena MS, Steele HL, Ramamurthy B, Ramalingam TS, Cohen AN, et al. Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 2005;11:6994–7002.
138. Mudduluru G, George William JN, Muppala S, Asangani IA, Kumarswamy R, Nelson LD. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep 2011;31:185–97.
139. Kunnumakkara AB, Diagaradjane P, Guha S, Deorukhkar A, Shentu S, Aggarwal BB. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Clin Cancer Res 2008;14:2128–36.
140. Dorai T, Cao YC, Dorai B, Buttyan RK. Therapeutic potential of curcumin in human prostate cancer. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 2001;47:293–303.
141. Mukhopadhyay A, Bueso Ramos C, Chatterjee D, Pantazis PA. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 2001;20:7597–609.
142. McCarty MF. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy. Integr Cancer Ther 2004;3:349–80.
143. Sundram V, Chauhan SC. Emerging roles of protein kinase D1 in cancer. Mol Cancer Res 2011;9:985–96.
144. Chun KS, Keum YS, Han SS, Song YS, Kim SH. Curcumin inhibits phorbol esterinduced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signalregulated kinase activity and NF-kappaB activation. Carcinogenesis 2003;24:1515–24.
145. Klinger NV, Mittal S. Therapeutic potential of curcumin for the treatment of brain tumors. Oxid Med Cell Longevity 2016;2016:1-14.
146. Perry MC, Demeule M, Regina A, Moumdjian RB. Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. Mol Nutr Food Res 2010;54:1192–201.
147. Wu B, Yao H, Wang SX. DAPK1 modulates a curcumin-induced G2/M arrest and apoptosis by regulating STAT3, NF-?B, and caspase-3 activation. Biochem Biophys Res Commun 2013;434:75–80.
Statistics
34 Views | 22 Downloads
Citatons
How to Cite
KRISHNAMURTHY, G., ROY, D., & KUMAR, J. (2020). CURCUMIN, A NATURAL GOLDEN DRUG AND ITS ANTICANCER ASPECTS FROM SYNTHESIS TO DELIVERY: A REVIEW. International Journal of Applied Pharmaceutics, 12(5), 70-84. https://doi.org/10.22159/ijap.2020v12i5.38586
Section
Review Article(s)